Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 11 Adenocarcinoma of Lung 4 Rectal Neoplasms 3 Triple Negative Breast Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Neoplastic Cells, Circulating 1 Lymphedema 1 Lung Neoplasms 1 Carcinoma, Lobular 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Ductal, Breast 1

Interventions

Blood Specimen Collection 5 Liquid Biopsy 2 Folfox protocol 2 Carboplatin 2 pertuzumab 1 Trastuzumab 1 Surgical Procedures, Operative 1 Standard of Care 1 Sevoflurane 1 Radiotherapy, Adjuvant 1 Propofol 1 Positron Emission Tomography Computed Tomography 1 Paclitaxel 1 Neoadjuvant Therapy 1 Mastectomy, Segmental 1 Gemcitabine 1 Fluorouracil 1 Epirubicin 1 Drug Therapy 1 Docetaxel 1 Cyclophosphamide 1 Colonography, Computed Tomographic 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Capecitabine 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplastic Cells, Circulating × Mastectomy, Segmental × Clear all

NCT04902937 2023-11-28

CETC

University of Jena

Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡